Skip to main content
Clinical Trials/CTRI/2024/05/068093
CTRI/2024/05/068093Not yet recruitingPhase 3

To Compare Central Macular Thickness in Patients Undergoing Phacoemulsification with or without Intravitreal Dexamethasone Injection in Patients with Coexisting Diabetic Macular Edema - NI

orthern Railway Central Hopital0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Sponsor

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1.Type 1 and 2 Diabetes Mellitus.
  • 2.Visual Acuity of 6/12 or less.
  • 3.Central macular thickness of 300 microns or less.
  • 4.Any gender.

Exclusion Criteria

  • 1 Any co-existing retinal pathology apart from diabetic retinopathy likely to affect visual acuity.
  • 2 Vitrectomised Eye.
  • 3 Uncontrolled Diabetes defined of HbA1c more than 10 percent.
  • 4 Any intra operative or post-operative complication effecting the visual acuity.

Investigators

Sponsor
orthern Railway Central Hopital

Similar Trials